Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight
Barbara A Sullivan, Richard Collis, Rhea Cahayag, Hector M Lopez, Mary Grace Baker, Emil D Kakkis, Syeda Rahman, Danny Bega, Margo Sheck Breilyn, John J Mitchell, Andrew A Grimm · 2026
Read Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight by Barbara A Sullivan, Richard Collis, Rhea Cahayag, Hector M Lopez, Mary Grace Baker, Emil D Kakkis, Syeda Rahman, Danny Bega, Margo Sheck Breilyn, John J Mitchell, Andrew A Grimm (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675699.txt.
Description
Barbara Sullivan and co-authors write, in 2026, about strong reactions that can strike during gene therapy infusions. These events hit during the drip or within six hours after it. They can look like severe allergy and may force doctors to stop treatment.
The paper draws on three real cases across two gene therapy products. One treated a glycogen storage disease and the other Wilson's disease. In each case, a fast infusion rate was part of the picture, even when patients got fever and allergy drugs first. Knowing the true mechanism behind a reaction changes how teams respond. The authors use that insight to guide safer handling, so patients can still receive a one-time therapy.
Catalog record
| CREATOR | Barbara A Sullivan, Richard Collis, Rhea Cahayag, Hector M Lopez, Mary Grace Baker, Emil D Kakkis, Syeda Rahman, Danny Bega, Margo Sheck Breilyn, John J Mitchell, Andrew A Grimm |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |